提供支持Dami and Xiaomi, a service platform for children with autism spectrum, announced that they have completed tens of millions of dollars in Series C financing. This round of financing was led by OrbiMed, and investors in the previous round continued to invest. China Renaissance Capital acted as the exclusive financial advisor for this round of financing.
Dami and Xiaomi revealed that this round of financing will be used to promote the construction of intervention rehabilitation products and service systems, intelligent solutions, and build inclusive offline institutions and public welfare training in small and medium-sized cities. Prior to this, Dami and Xiaomi had successively received investments from Fortune Venture Capital, Yuansheng Venture Capital, Wanwu Capital, and AquaVentures.
Founded in September 2014, Dami and Xiaomi are a company that focuses on the rehabilitation of children with autism (autism) and widespread child developmental disabilities, providing rehabilitation services, integrated education support, parent training, online courses and popular science information, etc. Integrated services. At present, Dami and Xiaomi have opened more than ten intervention and rehabilitation centers in Beijing, Shanghai, Guangzhou, Shenzhen, Zhengzhou, Nanjing, Hangzhou and other places, and are actively promoting the construction of integrated kindergartens for children with autism.Dami and Xiaomi have also assembled a multidisciplinary team including rehabilitation for children with autism, the Internet, artificial intelligence, and machine learning, including more than 20 academic consultants, more than 20 licensed behavior analysts, and more than 10 registered speech and functional therapists. , Nearly 600 first-line rehabilitation therapists work together to solve the social problems of children with autism and developmental disabilities.
About OrbiMed
OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals to medical devices and diagnostics.
渝公网安备 50011202502165号
